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A B S T R A C T   
Background: The higher prevalence of major depressive disorder (MDD) in females relative to males is well- 
established. Some authors have posited this difference arises to divergent symptom profiles in females vs. males. 
However, empirical tests of this hypothesis have yielded equivocal results. Here, we investigate sex differences in 
MDD of individual symptoms and symptom networks in a treatment-seeking sample. 
Methods: We assessed depressive symptoms using Hamilton Depression Rating Scale (HDRS-17) in 590 treat-
ment-seeking adults with MDD (300 females). We examined group differences in symptom endorsement. We 
investigated symptom networks and estimated Gaussian Graphical Models. Finally, we compared the female and 
male networks using the Network Comparison Test. 
Results: Females scored significantly higher in psychological anxiety (p <0.001; rB = -0.155), somatic anxiety 
(p = .001; rB = -0.150) and feelings of guilt (p = .002; rB = -0.139). Male and female patients did not differ in 
depression sum scores. There were no sex differences in network structure or global strength. 
Limitations: Our study was sufficiently powered to detect only medium sized symptom differences. The gen-
eralizability of our study is limited to clinical samples and further studies are needed to investigate if findings 
also translate to outpatient samples. 
Conclusion: Females reported elevated anxiety symptoms and guilt. Clinicians should assess these symptom 
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differences and tailor treatment to individual symptom profiles. No differences between sexes emerged in MDD 
network structures, indicating that features may be more similar than previously assumed. Sex differences in 
psychopathological features of MDD are important for future research and personalized treatment.   
1. Introduction 
The increased prevalence of major depressive disorder (MDD) in fe-
males compared to males has been reported consistently over time and in 
different populations (Kessler et al., 2003; Lim et al., 2018). The reason 
for these differences in prevalence has been attributed to various under-
lying sex differences, for example in neurobiology (Rubinow and 
Schmidt, 2019) and the prevalence of subtypes of depression 
(Silverstein et al., 2017). With regard to the latter, multiple studies found 
that females are more often affected by “atypical” depression (Angst et al., 
2002; Marcus et al., 2008). Atypical depression is defined by a specifier of 
MDD in different versions of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) by the predominance of symptoms such as 
weight gain or hypersomnia (Blanco et al., 2012; Marcus et al., 2008) 
compared to symptoms considered more typical such as disturbances of 
appetite and sleep disturbances. Depressed females tend to report more 
somatic symptoms (e.g., gastrointestinal symptoms and loss of appetite; 
(Angst et al., 2002; Silverstein et al., 2013) and further symptoms not 
included in the DSM definition of MDD (e.g., loss of libido and anxiety;  
Martin et al., 2013). One meta-analysis included data from 32 studies 
with a total of 108,260 individuals and found differences in the symptom 
profiles of females and males. Females reported higher intensity of so-
matic symptoms (e.g., sleep disturbance or fatigue) but also of core 
symptoms of depression (e.g., depressed mood or diminished interest;  
Cavanagh et al., 2017). Males presented more often with impulse control 
problems and substance use (e.g., nicotine/tobacco; Lamers et al., 2011). 
These differences, however, were moderate and heterogeneity was gen-
erally large. This might be due to the vast variety of measures used to 
assess depressive symptoms across studies, variances in definitions of 
depression and symptoms, and differences in participant samples and 
study designs (Cavanagh et al., 2017). Thus, it is not surprising that nu-
merous different factor structures of depression have been proposed 
(Pancheri et al., 2002). Consequently, there is also evidence that differ-
ential symptom profiles may be associated with distinct risk factors 
(Fried et al., 2014). Several risk factors (depression history, childhood 
stress, stressful life events, and sex) all predicted progression of depressive 
symptoms, they each had a specific association to individual depressive 
symptoms (Fried et al., 2014). Moreover, there is evidence that cognitive 
and memory biases are more strongly related to some, but not all, 
symptoms of depression (Beevers et al., 2019; Marchetti et al., 2018). 
Finally, treatment of depression does not affect all symptoms uniformly 
(Boschloo et al., 2019; Mullarkey et al., 2020). Taken together, this adds 
to the importance of symptom-level approaches in depression research. 
Differences on the symptom level are of relevance when depression is 
investigated from a network approach perspective (Fried et al., 2017). 
This approach conceptualizes mental disorders based on a complex sys-
tems theory framework as the interaction of their symptoms 
(Borsboom and Cramer, 2013). For example, in depression, insomnia 
may lead to concentration problems. This may then negatively impact 
one's performance at work, which again exacerbates insomnia, because 
one ruminates about the low performance at work (Cramer et al., 2016). 
According to Borsboom (2017), current conceptualizations of mental 
disorders presume an underlying latent disease entity to be the common 
cause of the symptoms that reflect its presence. From this perspective, 
symptoms are conceptualized to be diagnostically equivalent and inter-
changeable (Cramer et al., 2010; Lux and Kendler, 2010) and can 
therefore be summed up to an overall score indicating the severity of a 
mental disorder (Fried, 2015; Fried and Nesse, 2015b). This seems not 
only clinically implausible, but also negates the potential relevance of 
differences in symptom profiles of depression in females and males. 
While traditional conceptualizations have their shortcomings, novel ap-
proaches may be an alternative. The network approach posits that 
symptom co-occurrence arises not from a common underlying cause, but 
from symptom-to-symptom interactions (Borsboom, 2017). From this 
network perspective, differences between groups in the severity of in-
dividual symptoms or the interactions among those symptoms are ex-
ceedingly important as they indicate the possibility of differences be-
tween those groups in the causes of depression. Nevertheless, it has been 
noted, that the contrast between the two interpretations of correlations 
among symptoms (reflecting an underlying disorder versus a causal 
network), is likely less dogmatic than often pictured (Bringmann and 
Eronen, 2018). Furthermore, there is no general test to investigate if the 
“true” model is a network or a factor model (Fried, 2020). 
Although there are numerous studies that investigate depression 
from a network perspective (e.g., van Borkulo et al., 2015), including 
studies about the association of depressive symptoms with environ-
mental and genetic risk factors (van Loo et al., 2018) and co-expression 
of symptoms of anxiety and depression (Beard et al., 2016), only one 
study has analyzed sex differences (Mullarkey et al., 2018).  
Mullarkey et al. (2018) found that the depressive symptom networks of 
646 male and 744 female adolescents from the general population 
differed in one relationship between two symptoms, namely that the 
association between self-hatred and negative body image was stronger 
in females. In another non-peer-reviewed preprint, van Borkulo 
et al. (2017) reported no differences between the symptom networks of 
depressive symptoms of 351 male and 701 female adults of a clinical 
population. To our knowledge, no published study has analyzed both 
sex differences in depression symptom networks in adults, despite the 
importance of these analyses for our understanding of depression and 
the role of sex in its development. The main purpose of the study was an 
explorative assessment of sex differences in depressive symptom pro-
files and symptom networks in a clinical sample of adults with a di-
agnosis of MDD. We investigated the interaction of these symptoms in 
treatment seeking patients of a psychiatric hospital. 
2. Methods 
2.1. Participants and procedure 
As part of the regular clinical documentation at admission to the 
department for affective disorders at the Psychiatric Hospital of the 
University of Zurich, Switzerland, inpatients and day-clinic patients 
undergo basic clinical assessment. Data were collected as part of the 
routine clinical care procedure and completely anonymized. No specific 
written informed consent was thus obtained. 
We analyzed data from patients admitted during July 2007 to June 
2018. For this study, inclusion criteria were: age between 18 and 70, 
clinical diagnosis of major depressive disorder (single episode or re-
current; ICD-10 code F32 or F33; World Health Organization, 1992) as 
the main diagnosis, and data was only included from the first admis-
sion. To ensure the same power for detecting differences for all symp-
toms, we excluded participants if they failed to provide rating for all 
HDRS-17 items. Among the 611 patients who met the inclusion criteria, 
this led to the exclusion of additional 21 participants, leaving a final 
sample of 590 patients (300 female and 290 male patients). 
3. Measures 
Sex was determined as a binary variable (female, male). Individual 
sex was obtained from the patient's electronic patient record, which is 
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documented in accordance with the sex on the official ID-card or 
passport. 
Depressive symptoms were assessed using the clinician-adminis-
tered Hamilton Depression Rating Scale (HDRS-17; Hamilton, 1960). 
Clinically experienced physicians and psychologists completed HDRS 
questionnaires during the first three days of admission. The intensity of 
some symptoms (e.g., depressed mood, suicidal ideation, decreased 
interest, or psychomotor retardation) was rated from 0 to 4 (0 = none/ 
absent to 4 = most severe), whereas other symptoms’ intensity (e.g., 
decreased appetite or general somatic symptoms) was rated from 0 to 2 
(0 = none/absent to 2 = severe). The HDRS-17 has extensively been 
used in research on depression (Trajković et al., 2011). The reliability of 
the total depression symptom scale derived in our study (Cronbach's 
α = 0.74) was comparable to other studies (Trajković et al., 2011). 
3.1. Statistical analyses 
First, we compared females and males on both their overall HDRS 
score as well as their endorsement of individual HDRS items. Due to evi-
dence of a non-normal distribution of the data, we used non-parametric 
Mann-Whitney U tests. To control for the family-wise error rate, 
Bonferroni correction was applied. Given the current sample size and 
global alpha level of 0.05, post-hoc power to detect small, medium and 
large effects (d = 0.2, 0.5, 0.8; Cohen, 1988), was 0.68, 1.00 and 1.00, 
respectively (calculated with g*power; Faul et al., 2009). Second, we used 
network analysis to examine relationships among HDRS items. We mod-
eled our network analyses after those completed by Fried et al. (2017), and 
structured our results using the four components identified by those au-
thors: (a) network estimation; (b) network characterization; (c) network 
stability, and (d) network comparison. All network analyses were carried 
out using R version 3.6.2. Networks were visualized using the R-package 
qgraph (Epskamp et al., 2012). All other statistical analyses were con-
ducted with JASP Version 0.9.2.0 (JASP Team, 2020). 
Given that a lack of variability of an item can bias the network 
structure (Terluin et al., 2016), we checked the variance of all items. 
One item (Insight) showed very low variability and was therefore ex-
cluded from the network analysis. In addition, prior to network esti-
mation, we tested if the included symptoms overlapped, using the 
suggested default settings of the goldbricker function of the networktools 
package (Jones, 2019). This analysis suggested that the items Insomnia 
– Early and Insomnia – Middle had more than 75% (but less than 90%) of 
topologically overlapping correlations. Thus, we investigated the effect 
of removing each item individually on our results in two sensitivity 
analyses. Further details are available in the supplement. 
3.1.1. Network estimation 
Following the recommendations for network analysis with cross- 
sectional ordinal data (Costantini et al., 2017; Epskamp et al., 2018), 
we estimated partial correlation networks. In the resulting network (a 
Gaussian Graphical Model; GGM), nodes represent symptoms of de-
pression, and edges represent partial correlations between symptoms. 
The techniques used to estimate the networks are both based on gra-
phical lasso, which is a regularization procedure (Costantini et al., 
2017; Epskamp et al., 2018). First, we used the Fused Graphical Lasso 
(FGL) to estimate the networks for females and males jointly. We used 
the information criterion based FGL, to facilitate comparison with in-
dividually estimated networks (Costantini et al., 2017). Second, we 
estimated the networks for the subsamples individually for technical 
reasons (e.g., stability analysis is only available for individually esti-
mated networks, see below). We used the R-packages bootnet (Version 
1.2.2) (Epskamp et al., 2018) and EstimateGroupNetwork (Costantini and 
Epskamp, 2017). 
Table 1 
Demographic and clinical characteristics (n = 590).         
Variables Females (n = 300) Males (n = 290) χ2 p-value 
n % n %  
MDD, single episode (F32) 120 40 113 39 .66 .797 
MDD, recurrent episode (F33) 180 60 177 61 .66 .797 
Medicationa 219 73 213 73.4 .015 .902 
Non-psychotropic drugs 88 29.3 109 37.6 4.52 .034 
Antidepressants 198 66 190 65.5 .015 .902 
Anxiolytics 48 16 35 12.1 1.89 .170 
Detoxication and withdrawal 1 .3 3 1 1.08 .299 
Hypnotics 28 9.3 24 8.3 .21 .651 
Neuroleptics 84 28 65 22.4 2.44 .118 
Mood stabilizers 36 12 38 13.1 .164 .686 
Stimulants 5 1.7 10 3.4 1.89 .169 
Patients with comorbid diagnosesb 160 53.3 165 56.9 .76 .384 
F00 - F09 0 0 0 0 - - 
F10 - F19 53 17.7 80 27.6 8.31 .004⁎ 
F20 - F29 2 0.7 4 1.4 .74 .388 
F30 - F39 12 4 8 2.8 .69 .405 
F40 - F48 74 24.7 76 26.2 .19 .668 
F50 - F59 21 7  1 13.45 .000* 
F60 - F69 44 14.7 22 7.6 7.44 .006 
F70 - F79 0 0 1 .3 1.04 .309 
F80 - F89 0 0 0 0 - - 
F90 - F98 9 3 14 4.8 1.32 .252 
MDD = Major depressive disorder 
a Patients can take more than one drug. 
b Patients can have more than one comorbid diagnosis. 
⁎ p < .05. ⁎⁎p < .01. – Adjusted p-value for medication: 0.00625 – Adjusted p-value for comorbidities: 0.005 
F00-F09: Mental disorders due to known physiological conditions, F10-F19: Mental and behavioral disorders due to psychoactive substance use, F20-F29: 
Schizophrenia, schizotypal and delusional disorders, F30-F39: Mood [affective] disorders, F40-F48: Neurotic, stress-related and somatoform disorders, F50-F59: 
Behavioral syndromes associated with physiological disturbances and physical factors, F60-F69: Disorders of adult personality and behavior, F70-F79: Mental re-
tardation, F80-F89: Disorders of psychological development, F90-F98: Behavioral and emotional disorders with onset usually occurring in childhood and adolescence. 
F30 - F39: Mood [affective] disorders, F40 - F48: Neurotic, stress-related and somatoform disorders, F50- F59: Behavioral syndromes associated with physiological 
disturbances and physical factors, F60 - F69: Disorders of adult personality and behavior, F70 - F79: Mental retardation, F80-F89: Disorders of psychological devel-
opment, F90-F98: Behavioral and emotional disorders with onset usually occurring in childhood and adolescence.  
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We used the graphical lasso estimation procedure to estimate the 
networks (Epskamp et al., 2018). First, we used the Fused Graphical 
Lasso (FGL) to estimate the networks for females and males jointly. We 
used the information criterion based FGL, to facilitate comparison with 
individually estimated networks (Costantini et al., 2017). Second, we 
estimated the networks for the subsamples individually for technical 
reasons (e.g., stability analysis is only available for individually esti-
mated networks, see below). 
3.1.2. Network characterization 
Subsequently, we examined the characteristics of individual nodes 
within the network. First, we computed undirected strength centrality to 
assess the relative interconnectedness of nodes in a network. Next, we 
estimated “predictability” using the mgm package (Haslbeck and 
Waldorp, 2016). “Predictability” is the upper bound of the shared variance 
of a given node (measured in R2) with all its neighbors, assuming that all 
connections go towards the given node (Haslbeck and Fried, 2017). 
3.1.3. Network stability 
Stability and accuracy analyses, as well as the estimation of predict-
ability are not yet available for jointly estimated networks. We used the R- 
package bootnet Version (1.1) (Epskamp et al., 2018) to assess the stability 
for the individually estimated networks, reflecting a lower bound for 
stability for the jointly estimated networks. Bootnet uses bootstrapping 
procedures to compute 95% confidence intervals for the edge weights, and 
to calculate the correlation-stability coefficient. We performed edge 
weights difference test and centrality difference tests. The results of all 
these analyses are outlined in the Supplementary materials. 
3.1.4. Network comparison 
We used the R-package NetworkComparisonTest (NCT; van Borkulo 
et al., 2017) to test for differences in network structure (assuming that 
the structure of both networks is exactly the same), global strength 
(assuming that overall connectivity in both networks is exactly the 
same) and edge strength (assuming that all edges of both networks are 
of similar strength) between the female and male symptom networks 
(van Borkulo et al., 2017). 
4. Results 
4.1. Sample characteristics 
Average age (in years) did not differ between females (M = 43.44, 
SD = 12.80) and males (M = 43.99, SD = 12.26); t(1) = 0.524, 
p = .601). Female and male patients did not differ in their main di-
agnosis (F32 or F33), use of medication, or the comorbidity with an 
additional mental disorder. However, males were more likely to have 
an additional diagnosis of Mental and behavioral disorders due to 
psychoactive substance use (F10-F19). Females were more likely to 
have an additional diagnosis of disorders associated with physiological 
disturbances and physical factors (F55-F59). Further sample char-
acteristics are presented in Table 1. 
4.2. Individual MDD symptoms 
We found no sex difference in the sum score of the HDRS-17. 
Regarding individual items, female patients had higher ratings in 
Anxiety Psychic (p <0.001; W = 36,763; rB = −0.155), Anxiety Somatic 
(p = .001; W = 36,979; rB = −0.150) and Feelings of Guilt (p = .002; 
W = 37,468; rB = −0.139). No item was more frequently endorsed by 
males. Mean scores and standard deviations for each of the 17 de-
pression symptoms indexed by the HDRS are presented in Fig. 1. Two 
sensitivity analyses, individually excluding patients with an additional 
F10-F19 or F50-F55 diagnoses showed the same differences (for more 
details see the Supplementary materials). 
4.3. MDD symptom networks 
The networks for males and females are presented in Fig. 2. The 
NCT revealed no differences between sexes in network structure 
(p = .5578), or global strength (p= .2626; see R script for more de-
tails). Because the network structure was found to be invariant, we did 
not test individual connection strengths (van Borkulo et al., 2017). 
Neither removing Insomnia – Middle or Insomnia – Early from the net-
work, as suggested by the goldbricker function, nor excluding patients 
with an additional F10-F19 or F50-F59 diagnosis altered the results (see 
Supplementary Materials). In accordance with the NCT, visual inspec-
tion of the network suggests that depressive symptom networks for 
females and males shared many edges and network features. Across 
both sexes, Somatic Symptoms – Gastro-intestinal and Loss of Weight were 
strongly connected. There were also strong connections among the 
three Insomnia items, as well as connections between Anxiety Somatic 
and Hypochondriasis in both males and females. Agitation showed the 
weakest edges in both sexes’ networks. 
4.4. Individual networks 
4.4.1. Centrality 
Node strength estimations are shown in Figure S1. For both sexes, 
nodes with high strength values were Depressed Mood and Anxiety 
Somatic. For females, the node with the highest strength was Insomnia – 
Middle, for males Depressed Mood. Agitation had lowest centrality esti-
mates in both sexes. However, the CS-coefficient for strength for the 
female networks was 0.440 and the male network 0.438, both not ex-
ceeding the recommended threshold of 0.5 (Epskamp et al., 2018). In 
line with these results, the significance testing revealed that only Agi-
tation had lower centrality than most other items in the female and male 
network (Figure S2 for females and Figure S3 for males). In the male 
Fig. 1.  Mean endorsement for each symptom for female 
(n = 300) and male patients (n = 290). 
Standard error is presented in the figure by the error 
bars. 
DeprMD = Depressed Mood, Guilt = Feelings of Guilt, 
Suic. = Suicidal ideation, InsEa = Insomnia – Early, 
InsMid = Insomnia – Middle, InsLa = Insomnia – Late, 
WorkAct = Work and Activities, Retard = Retardation, 
Agit = Agitation, AnxPsy = Anxiety Psychic, 
AnxSom = Anxiety Somatic, SomGast = Somatic 
Symptoms – Gastro-intestinal, SomGen = Somatic 
Symptoms – General, Genital = Genital Symptoms, 
Hypoch = Hypochondriasis, Weight = Loss of Weight; 
Insight = Insight. 
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network, Depressed Mood exhibited greater node strength than the 
majority of the other symptoms (Figure S3). Details and results of the 
significance tests for the individual edge weights are available in the 
Supplementary materials. 
4.4.2. Predictability 
For both sexes, Agitation had the lowest predictability. Highest 
predictability was found for Insomnia – Middle (0.367) in females and 
for Depressed Mood (0.414) in males. Mean predictability was 0.214 for 
females and 0.224 for males. 
5. Discussion 
The current study investigated sex differences in depressive 
symptom profiles and in the corresponding symptom network structure 
in an adult, treatment-seeking population suffering from major de-
pressive disorder. Females reported more anxiety and more feelings of 
guilt than males. We did not find any additional sex differences in in-
dividual symptom endorsement or in the overall sum score. Moreover, 
no differences in symptom networks emerged. 
In accordance with a meta-analysis on sex differences in depressive 
symptoms by Cavanagh et al. (2017), we found that females reported 
more anxiety than males. Moreover, this was the case for both psychic 
(e.g., disproportional worries or fear) and somatic symptoms (e.g., 
tremor or sweating) of anxiety. It is important to note that we based our 
analyses on a treatment seeking population and our data facilitated an 
estimation of the effect of comorbidities, while in the aforementioned 
meta-analysis (Cavanagh et al., 2017) none of the included studies re-
ported any existing comorbidities. Also, in line with the meta-analysis 
was the small effect size for both differences. One reason females report 
more anxiety might be a higher prevalence of comorbid anxiety disorders 
in females, which has been well documented (McLean et al., 2011;  
Simonds and Whiffen, 2003). In our sample, however, the rate of co- 
morbidity with a neurotic, stress-related, or somatoform disorders (F4;  
World Health Organization, 1992), which include anxiety disorders, was 
equal in both sexes, suggesting that differences in comorbid anxiety 
cannot account for our findings. Hence, further research is needed to 
identify and evaluate potential causes for the increased level of anxiety in 
females with MDD. Independent of the underlying cause, increased levels 
of anxiety have been shown to negatively impact the efficacy of treat-
ment in MDD (Fava et al., 2008). Therefore, clinicians should carefully 
assess symptoms of anxiety in MDD patients, especially in females. Ad-
ditionally, clinicians should be aware that males may tend to underreport 
anxiety symptoms (Bekker and van Mens-Verhulst, 2007), resulting in a 
reporting bias (but also see McLean and Hope, 2010). 
We also found females to express more feelings of guilt than males. 
Comparing our result with the meta-analysis by Cavanagh et al. (2017) 
has limited validity, because they combined worthlessness and guilt in 
one item. Still, they did not find a significant difference for the composite 
item. Our results and also the effect sizes, however, are in line with the 
sex difference in experiencing guilt in general (Else-Quest et al., 2012). 
Because our sample consisted of treatment-seeking individuals, an ad-
ditional reason for higher levels of guilt in females might be the increased 
attention to emotions in females with severe depression (Thayer et al., 
2003). Hence, we suggest clinicians to be aware of elevated levels of guilt 
in this sub-population. Moreover, clinicians should be mindful of the 
presence of anxiety and guilt in female patients, considering the potential 
role of these symptoms within the patients’ case conceptualizations and, 
therefore, assess these symptoms pro-actively. Our results may suggest a 
focus on anxiety and guilt as possible treatment targets. 
No other sex differences in symptom severity emerged. This is also 
partially consistent with the meta-analysis by Cavanagh et al. (2017). 
They did not find sex differences with regard to suicidality, psycho-
motor retardation and hypochondriasis. However, in contrast with our 
findings, they reported that females suffered more from depressed 
mood, problems with sleep, somatic difficulties and problems with 
appetite or weight. There are several potential reasons for these dif-
ferent findings. First, the meta-analysis covered symptoms assessed 
with different questionnaires. Thus, the HDRS symptoms did not ex-
actly match with the items analyzed in the meta-analysis. Second, re-
garding the results of the individual studies, the heterogeneity was 
mostly high (Cavanagh et al., 2017). This limits the grade of evidence of 
Fig. 2. Network of depressive symptoms for female (left, n = 300) and male (right, n = 290) treatment-seeking adults. 
Nodes represent symptoms, edges partial correlations. Blue edges indicate positive, red edges negative correlations. The bigger the partial correlation, the ticker the 
edge. The gray area in the rings around the nodes depicts predictability (the upper bound of variance of a given node explained by all its neighbors), with a full circle 
corresponding to an R2 of 1. 
DeprMD = Depressed Mood, Guilt = Feelings of Guilt, Suic. = Suicidal ideation, InsEa = Insomnia – Early, InsMid = Insomnia – Middle, InsLa = Insomnia – Late, 
WorkAct = Work and Activities, Retard = Retardation, Agit = Agitation, AnxPsy = Anxiety Psychic, AnxSom = Anxiety Somatic, SomGast = Somatic Symptoms – 
Gastro-intestinal, SomGen = Somatic Symptoms – General, Genital = Genital Symptoms, Hypoch = Hypochondriasis, Weight = Loss of Weight; Insight = Insight. 
(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) 
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the meta-analysis. One of multiple reasons underlying this hetero-
geneity is the varying method of symptom assessment. Several studies 
found significant differences in overall self-reported symptom severity. 
However, no significant sex differences were found in clinical assess-
ments (Dekker et al., 2008; Kornstein et al., 2000; Scheibe et al., 2003). 
We used the same type of assessment, i.e., clinician-based, and this has 
to be considered. Third, the effect sizes reported in the meta-analysis by  
Cavanagh et al. (2017) were small or even very small. Our study 
achieved a post-hoc calculated power of 0.69 for small effect sizes after 
the correction for the family-wise error rate. Hence, our limited power 
may have resulted in false negative findings (see limitations). 
We did not find any sex differences regarding the network structure or 
global network strength. This is in line with the results of  
Mullarkey et al. (2018) who reported no difference in global strength in 
depressive symptom networks of female and male adolescents. Although 
they found the network structure to be different across the two sexes, this 
was due to one out of dozens of edges. Furthermore, this edge was be-
tween two symptoms not commonly attributed to depression, namely self- 
hatred and negative body image. Our findings are also in line with a 
preprint by van Borkulo et al. (2017), which found no sex differences in 
symptom networks in depressed adults. There are several potential reasons 
for these null findings. First, the NCT is a conservative test (van Borkulo 
et al., 2017; Williams et al., 2019). Therefore, investigations with larger 
samples might be able to detect sex differences in network structures. 
Moreover, additional statistical tools for comparing networks are under 
current development (e.g., Haslbeck et al., 2019) and at least one will have 
higher power to find differences (Williams et al., 2019). Applying these 
methods, once available, might reveal sex differences. Second, statistical 
power to detect the effect of a variable on network structure depends on 
the sample and effect size, but also on the model (i.e., the symptoms in-
cluded). A GGM is estimated on the basis of all individual symptoms’ 
variance accounted for by all other included symptoms (Epskamp et al., 
2018). Consequentially, when networks are compared with each other, 
only the shares of the variance accounted for by the networks are com-
pared with each other (e.g., using the NCT; van Borkulo et al., 2017). 
Hence, given an effect and sample size, the statistical power of the NCT 
directly relates to the total amount of variance accounted for by the 
models which are compared with each other. Predictability is an estimate 
for the upper bound of variance (measured in R2) of a given symptom 
explained for by all other items in the network. In our study, mean pre-
dictability was approximately 0.2 for both sexes, which is comparable to 
the mean predictability in other studies of networks of depressive symp-
toms (Haslbeck and Fried, 2017). In other words, on average at least 80% 
of a symptom's variance was not explained by other symptoms. This ad-
ditionally limits the power of the NCT. Moreover, such values for mean 
predictability are not only low absolute values, but also relatively low, 
when compared to mean predictability in network models of other dis-
orders (Haslbeck and Fried, 2017). This indicates that symptom network 
models of depression perform badly at capturing the variance in symptoms 
of depression. This poses a significant challenge for all network models of 
MDD. One solution is comparing predictability of network models based 
on different symptoms sampled out of a set of depressive symptoms and 
selecting a model with high predictability. However, individual symptom 
profiles of MDD are known to have substantial heterogeneity (Fried et al., 
2016; Fried and Nesse, 2015a), which might limit the optimization of 
predictability in group-level network models of MDD per se. Third, as 
outlined above, sex differences in symptom profiles have a small effect size 
and individual findings are heterogeneous (Cavanagh et al., 2017). Fur-
thermore, given the high heterogeneity of individual symptom profiles 
(Fried and Nesse, 2015a), one could question the utility of group level 
network models of symptoms of depression at all. Moreover, the network 
approach perspective is primarily focused on within-subject, rather than 
between-subject effects (Borsboom, 2017). Thus, investigations of network 
models based on within-subject effects (e.g., Bringmann et al., 2015) may 
provide important additional information about the relationships among 
depression symptoms in males and females. 
5.1. Limitations 
This study has several limitations. First, our analysis focused on in-
dividual HDRS items and we did not investigate sex differences on the 
factor level of the HDRS (e.g., based on the factor structure described by  
Cleary and Guy (1977). Due to our focus on differences on the level of 
individual HDRS items, our limited sample size and the fact that the 
software to conduct latent network analysis (Epskamp et al., 2017b) was 
still under development, we did not estimate a latent network. Never-
theless, further research is needed to explore potential sex differences in 
latent networks of depression. Furthermore, such an investigation could 
also address a second limitation of our study, namely that some of the 
symptoms assessed with the HDRS probably measure overlapping con-
structs, which artificially inflates edge weights between these items. This 
was confirmed by the goldbricker function indicating topologically 
overlap between the items Insomnia – Early and Insomnia – Middle. As 
noted above, however, networks of females and males did not differ 
when either one of these items were excluded from the analysis. Third, as 
outlined above, our post-hoc calculated power to detected differences in 
symptom profiles with small effect size was 0.69. It is possible that we 
would have found more sex differences with greater power. However, to 
detect small effect sizes with sufficient power (0.9), while also ac-
counting for the family-wise error rate, an approximate sample size of 
1830 would have been needed. Fourth, although the HDRS is one of the 
most commonly used rating scales for depression (Santor et al., 2006), it 
does not reflect the current DSM-5 or ICD-10 definition of MDD. Still, its 
broad use enables comparability with existing literature. Fifth, the in-
vestigation of a clinical compared to a healthy population leads to 
spurious negative or weaker correlations between symptoms in a net-
work due to Berkson's bias (de Ron et al., 2019). This limits the gen-
eralizability of our findings based on network analysis to non-clinical 
populations. Sixth, to our knowledge, there is no possibility to calculate 
or estimate post-hoc power of an NCT-analysis. Thus, effective power of 
our analyses remains undetermined. In addition, the NCT is not designed 
to collect evidence for the null hypothesis. Consequently, we could not 
assess if the null hypothesis (that there are no sex differences in network 
structures) is true. Nevertheless, with future methodological advances 
(e.g., Bayesian methods for estimating GGMs; Williams et al., 2019) this 
will be possible. Lastly, sex was assessed as a binary variable based on 
participants’ sex in their official identity documents. Transgender people 
in Switzerland can change their sex in their identity documents but must 
choose between male or female. Therefore, no third option for sex be-
sides female or male was available. 
6. Future directions 
Based on our results and the limitations of our study, we have 
several suggestions for future research. With regard to sex differences of 
depressive symptom profiles, the heterogeneity of the existing literature 
should be addressed systematically. As an example, there is evidence 
that females with severe depression are more aware of their emotions 
(Thayer et al., 2003). Consequentially, the kind of symptom assessment 
(as a self-report or by a clinician) likely influences symptom reporting 
and comparison of symptom severity between females and males. We 
have several additional recommendations for research on sex differ-
ences in network models of MDD to the ones outlined above. First, our 
study needs to be replicated, especially with a bigger sample size to 
increase power. Second, future studies should investigate network 
structure in community samples, which avoids the induction of Berk-
son's bias. However, these results could only be compared to clinical 
samples under the assumption that the underlying network structure is 
independent of the severity of the symptoms. Third, we strongly re-
commend future studies to estimate predictability to assess the limits of 
their model in explaining individual symptoms’ variance. Our findings 
provide evidence, however, that there are no, or only subtle, sex dif-
ferences in the network structure of depressive symptoms. 
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7. Conclusion 
This study is amongst the first to investigate sex differences in de-
pressive symptoms and their corresponding network structure in adults. 
We found that females reported more symptoms of anxiety and guilt, 
which is in line with the literature. However, in a recent meta-analysis 
(Cavanagh et al., 2017), females were not found to have more symptoms 
of guilt. Similar to the two existing similar studies (Mullarkey et al., 
2018; van Borkulo et al., 2017), we found no sex differences in symptom 
network structures. Given that the sex differences in individual depres-
sive symptoms were of small effect, one potential reason for our null 
finding is the design of the used network analytic method, which is 
aimed to optimize specificity at cost of lower sensitivity. Taken together, 
our results indicate, that sex differences in depressive symptoms in 
treatment-seeking adults are few and subtle. 
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